A Set of Multiresistant Isolates of Mycoplasma bovis Subtype ST-1 with a Variable Susceptibility to Quinolones Are

Juan Carlos Corrales1, Antonio Sánchez1, Xóchitl Hernández1

  • 1Ruminant Health Research Group, Department of Animal Health, Faculty of Veterinary Sciences, University of Murcia, 30100 Murcia, Spain.

PubMed

Insights

A new subtype of Mycoplasma bovis (ST-1) has been identified in Spain, exhibiting fluoroquinolone resistance. This discovery necessitates updated diagnostic and therapeutic strategies for bovine respiratory complex diseases.

Area of Science:

  • Veterinary Microbiology
  • Bovine Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Mycoplasma bovis is a major cause of bovine respiratory complex diseases (RCD) globally.
  • Spanish endemic subtypes ST-2 and ST-3 show varying fluoroquinolone susceptibility, guiding control strategies.
  • Previous control strategies relied on subtype diagnosis for targeted therapy.

Purpose of the Study:

  • To report the emergence of a novel Mycoplasma bovis ST-1 subtype in Spain.
  • To investigate the antimicrobial susceptibility, particularly to fluoroquinolones, of this new ST-1 subtype.
  • To explore potential resistance mechanisms in the identified ST-1 isolates.

Main Methods:

  • Microbiological studies and isolation of Mycoplasma bovis from calves with respiratory symptoms.
  • Determination of minimum inhibitory concentrations (MICs) for a panel of antimicrobials, including fluoroquinolones.
  • Sequencing of quinolone resistance-determining region (QRDR) genes (gyrA, gyrB, parC, parE) in selected isolates.

Main Results:

  • The first detection of Spanish Mycoplasma bovis ST-1 isolates from calves with pneumonia across different regions.
  • Phenotypic variations in fluoroquinolone susceptibility were observed among ST-1 isolates, with no clear geographical correlation.
  • While some ST-1 isolates showed QRDR mutations associated with high fluoroquinolone MICs, not all did, suggesting alternative resistance mechanisms.
  • ST-1 isolates demonstrated resistance to macrolides and lincosamides, similar to Spanish ST-2 and ST-3 subtypes.

Conclusions:

  • The emergence of Mycoplasma bovis ST-1 in Spain presents a new challenge for RCD control.
  • Fluoroquinolone resistance in ST-1 isolates is complex, involving both QRDR mutations and potentially other uncharacterized mechanisms.
  • The co-resistance to macrolides and lincosamides in ST-1 highlights the need for comprehensive antimicrobial stewardship in affected herds.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Bacterial Phylum Tenericutes01:24

Bacterial Phylum Tenericutes

The phylum Tenericutes, which includes the single class Mollicutes, comprises bacteria that lack cell walls. The term "Mollicutes" derives from the Latin word mollis, meaning "soft." These organisms are among the smallest known and are commonly referred to as mycoplasmas due to the prominence of the genus Mycoplasma, which includes well-known human pathogens. Despite their inability to stain gram-positively (a result of their lack of cell walls), mycoplasmas are phylogenetically related to the...
680
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
245
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
151
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
106